SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-037230
Filing Date
2021-07-20
Accepted
2021-07-20 16:11:04
Documents
4
Period of Report
2021-07-20

Document Format Files

Seq Description Document Type Size
1 6-K ANNUAL MEETING RESULTS mito-6k_20210719.htm 6-K 49141
2 EX-99.1 THE COMPANIES LAW (AS AMENDED) COMPANY LIMITED BY SHARES FIFTH AMENDED A mito-ex991_22.htm EX-99.1 376113
3 GRAPHIC gmmur54f0do4000001.jpg GRAPHIC 6169
4 GRAPHIC gmmur54f0do4000002.jpg GRAPHIC 6488
  Complete submission text file 0001564590-21-037230.txt   444039
Mailing Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005
Business Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005 617-600-6888
Stealth BioTherapeutics Corp (Filer) CIK: 0001696396 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38810 | Film No.: 211101287
SIC: 2834 Pharmaceutical Preparations